Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 3/20 | 0.43 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.43 |
| ▸ | PARP3 | Q9Y6F1 | 2/20 | 0.43 |
| ▸ | MC4R | P32245 | 1/20 | 0.43 |
| ▸ | MC5R | P33032 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | CHKA | P35790 | 1/20 | 0.41 |
| ▸ | ICMT | O60725 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4846900 | 0.99 | CYP2D6 (0.48) | CYP2D6CYP2C9HIF1ASIGMAR1PRMT6 | |
| SCHEMBL4844432 | 0.82 | PRMT6 (0.58) | CYP2D6PRMT6KMT2ACHKASMN1; SMN2 | |
| SCHEMBL4844426 | 0.82 | PARP1 (0.56) | CYP2D6CYP2C9HIF1APRMT6PARP1 | |
| SCHEMBL4850572 | 0.81 | PRMT6 (0.56) | CYP2D6PRMT6KMT2ACHKASMN1; SMN2 | |
| SCHEMBL4850567 | 0.81 | PARP1 (0.57) | CYP2D6CYP2C9HIF1APRMT6PARP1 | |
| SCHEMBL28610633 | 0.78 | PRMT6 (0.63) | CYP2D6CYP2C9HIF1APRMT6PARP1 | |
| SCHEMBL4839412 | 0.76 | KMT2A (0.51) | SIGMAR1PRMT6MC4RMC5RMEN1 | |
| SCHEMBL4840245 | 0.76 | NCF1 (0.55) | CYP2D6PRMT6KMT2ACHKASMN1; SMN2 | |
| SCHEMBL4840229 | 0.76 | DPP8 (0.41) | CYP2D6CYP2C9HIF1ASIGMAR1PRMT6 | |
| SCHEMBL6706722 | 0.76 | ALDH1A1 (0.43) | CYP2D6CYP2C9HIF1APRMT6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7368462-B1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2008-05-06 | — | — | US | claimed |
| US-7368462-B1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2008-05-06 | — | — | US | disclosed |
| US-20080058423-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058423-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC4R | CYP2D6 1658/4885CYP2C9 3090/4885HIF1A 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.